These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4876741)

  • 1. Incidence and significance of chlorpromazine-induced eye changes.
    De Long SL
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular effects of phenothiazine derivatives and reversibility.
    Mathalone MB
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
    [No Abstract]   [Full Text] [Related]  

  • 3. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study.
    Prien RF; DeLong SL; Cole JO; Levine J
    Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574
    [No Abstract]   [Full Text] [Related]  

  • 4. Corneal and lens changes after prolonged treatment with chlorpromazine.
    Sandvig K
    Acta Ophthalmol (Copenh); 1965; 43(5):730-4. PubMed ID: 5898525
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular complications of phenothiazines.
    Mathalone MB
    Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs].
    Francesconi G; Di Tizio A; Cameo D
    Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709
    [No Abstract]   [Full Text] [Related]  

  • 7. [Damage to eyes through conservative therapy].
    Kleberger E
    Klin Monbl Augenheilkd; 1967; 151(6):777-801. PubMed ID: 4874408
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular and cutaneous side effects after prolonged chlorpromazine treatment.
    Gombos GM; Yarden PE
    Am J Psychiatry; 1967 Jan; 123(7):872-4. PubMed ID: 6016858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ultrastructural study of corneal thickening in the course of chlorpromazine treatment].
    Pouliquen Y; Graf B; Bisson J; Feuvrier YM; Delattre A
    Arch Ophtalmol Rev Gen Ophtalmol; 1970 Nov; 30(11):769-82. PubMed ID: 4250388
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ocular complications in chronic psychiatric patients caused by prolonged use of antipsychotic drugs (author's transl)].
    Yang Y
    Zhonghua Yan Ke Za Zhi; 1979; 15(3):198-200. PubMed ID: 45367
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ocular involvement during prolonged treatment with neuroleptics].
    Nouri A; Cuendet JF
    Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognosis of eye complications caused by phenothiazines.
    Forrest FM; Snow HL
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:26-8. PubMed ID: 5672560
    [No Abstract]   [Full Text] [Related]  

  • 14. Chlorpromazine and the eye of the dog. V. Attempt to produce lenticular lesions.
    Barron CN; Rubin LF; Steelman RL
    Exp Mol Pathol; 1972 Apr; 16(2):169-71. PubMed ID: 5062561
    [No Abstract]   [Full Text] [Related]  

  • 15. Asymmetric anterior segment changes induced by chlorpromazine.
    Deluise VP; Flynn JT
    Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ocular findings associated to the use of amiodarone].
    Riihelä K; Mäntyjärvi M
    Duodecim; 1996; 112(9):766-71. PubMed ID: 10592960
    [No Abstract]   [Full Text] [Related]  

  • 17. The incidence of treatment emergent symptoms under chlorpromazine and placebo conditions [proceedings].
    Guy W; Petrie W; Cleary P
    Psychopharmacol Bull; 1978 Apr; 14(2):22-4. PubMed ID: 349600
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ocular lesions caused by phenothiazines].
    Delorme R; Ballereau L; Baïkoff G; Quéré MA
    Bull Soc Ophtalmol Fr; 1973 Apr; 73(4):591-3. PubMed ID: 4152702
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular melanosis with special reference to chlorpromazine.
    Cameron ME
    Br J Ophthalmol; 1967 May; 51(5):295-305. PubMed ID: 6022771
    [No Abstract]   [Full Text] [Related]  

  • 20. Lens opacities and porphobilinogen-like substance in urine associated with levomepromazine.
    Kassman T; Wetterberg L
    Acta Psychiatr Scand; 1967; 43(2):163-8. PubMed ID: 6077783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.